This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Insights Into the Biology of Dermal Maturation

C. R. Jeanette Morales-Ducret, MD; Matt van de Rijn, MD; Bruce R. Smoller, MD

Arch Dermatol. 1995;131(8):915-918.

Abstract
Background and Design
Recently, a new category of oncogenes has been discovered that regulate programmed cell death. The bcl-2 oncogene has been found to inhibit cellular death without affecting cellular proliferation. In the skin, bcl-2 expression is limited to cells along the basal cell layer. However, we also noticed that resting melanocytes appeared to express bcl-2. We examined the expression of bcl-2 and its possible role in the biology of benign melanocytic proliferations. Routine paraffin sections of formalin-fixed tissue were labeled with anti-bcl-2 monoclonal antibody, and expression of bcl-2 was detected by a biotin-avidin-immunoperoxidase procedure.

Results
We examined 13 congenital, 11 acquired, and six atypical or dysplastic nevi for expression of bcl-2. Expression of bcl-2 was observed in 11 of 13 congenital nevi. All 11 acquired nevi and 6 nevi with architectural disarray and cytologic atypia expressed bcl-2. Both junctional and intradermal melanocytes expressed bcl-2 in a perinuclear and cytoplasmic pattern. Within neurotized areas, bcl-2 became significantly weaker and totally absent.

Conclusions
In mature tissues, bcl-2 expression is quite limited. It appears to be restricted to pluripotential stem cells that serve as a reservoir for tissue that is constantly undergoing renewal, such as the hematopoietic cells and the intestinal mucosa. In the skin, bcl-2 expression has been previously reported to be limited to the epidermal basal cell layer and proliferation zones. Our results indicate that resting melanocytes and melanocytic nevi regularly express ^bcl-2.

(Arch Dermatol. 1995;131:915-918)

Author Affiliations
From the Departments of Pathology (Drs Morales-Ducret, van de Rijn, and Smoller) and Dermatology (Dr Smoller), Stanford (Calif) University Medical Center.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

WT1 and Bcl2 Expression in Melanocytic Lesions of the Conjunctiva: An Immunohistochemical Study of 123 Cases
Furusato et al.
Arch Ophthalmol 2009;127:964-969.
ABSTRACT | FULL TEXT  

{alpha}-Melanocyte-stimulating Hormone Protects from Ultraviolet Radiation-induced Apoptosis and DNA Damage
Bohm et al.
J. Biol. Chem. 2005;280:5795-5802.
ABSTRACT | FULL TEXT  

Recent Advances in Melanoma Biology
Perlis and Herlyn
The Oncologist 2004;9:182-187.
ABSTRACT | FULL TEXT  

The Pathogenesis of Melanoma Induced by Ultraviolet Radiation
Gilchrest et al.
NEJM 1999;340:1341-1348.
FULL TEXT  

bcl-2 Expression in Primary Malignancies of the Skin
Morales-Ducret et al.
Arch Dermatol 1995;131:909-912.
ABSTRACT  

Differential Control of Cell Death in the Skin
Norris
Arch Dermatol 1995;131:945-948.
ABSTRACT